HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies

G-protein coupled receptor 119 (GPR119) has emerged as a novel target for the treatment of type 2 diabetes mellitus. GPR119 is involved in glucose-stimulated insulin secretion (GSIS) from the pancreatic β-cells and intestinal cells. In this study, we identified a novel small-molecule GPR119 agonist,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Kim, SoRa, Kim, Dae Hoon, Kim, Young-Seok, Ha, Tae-Young, Yang, Jin, Park, Soo Hyun, Jeong, Kwang Won, Rhee, Jae-Keol
פורמט: Artigo
שפה:Inglês
יצא לאור: The Korean Society of Applied Pharmacology 2014
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201229/
https://ncbi.nlm.nih.gov/pubmed/25414769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2014.035
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים